Inspire Medical Systems (NYSE:INSP – Get Free Report) and CareCloud (NASDAQ:CCLD – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.
Profitability
This table compares Inspire Medical Systems and CareCloud’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Inspire Medical Systems | 6.17% | 10.38% | 8.93% |
| CareCloud | 10.08% | 23.51% | 16.68% |
Earnings & Valuation
This table compares Inspire Medical Systems and CareCloud”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Inspire Medical Systems | $802.80 million | 2.89 | $53.51 million | $1.73 | 45.38 |
| CareCloud | $111.79 million | 1.31 | $7.85 million | ($0.04) | -86.75 |
Inspire Medical Systems has higher revenue and earnings than CareCloud. CareCloud is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Inspire Medical Systems has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500. Comparatively, CareCloud has a beta of 2.1, suggesting that its stock price is 110% more volatile than the S&P 500.
Institutional & Insider Ownership
94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 10.2% of CareCloud shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by company insiders. Comparatively, 14.7% of CareCloud shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Inspire Medical Systems and CareCloud, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Inspire Medical Systems | 1 | 7 | 7 | 0 | 2.40 |
| CareCloud | 1 | 2 | 1 | 0 | 2.00 |
Inspire Medical Systems currently has a consensus price target of $152.64, indicating a potential upside of 94.45%. CareCloud has a consensus price target of $2.50, indicating a potential downside of 27.95%. Given Inspire Medical Systems’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Inspire Medical Systems is more favorable than CareCloud.
Summary
Inspire Medical Systems beats CareCloud on 9 of the 14 factors compared between the two stocks.
About Inspire Medical Systems
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
About CareCloud
CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services. Its technology-enabled business solutions comprise revenue cycle management services, healthcare claims clearinghouse, and medical coding and credentialing services; electronic health records, practice management software and related capabilities, patient experience management solutions, business intelligence and healthcare analytics platforms, and customized applications, interfaces, and various other technology solutions, as well as artificial intelligence, such as CareCloud cirrusAI, AI-powered clinical decision support, AI-powered virtual support assistant, AI-driven appeals, and CareCloud cirrusAI. In addition, the company provides chronic care management, remote patient monitoring, and telemedicine solutions; and professional and consulting services, workforce augmentation and on-demand staffing, and strategic advisory services. Further, it offers medical practice management services to medical practices comprising appropriate facilities, equipment, supplies, support services, nurses, and administrative support staff, as well as management, bill-paying, and financial advisory services. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
